Evidence map›Paper›PMID 26015955›Full record

ArticleMolecular therapy. Methods & clinical development2014

Lentiviral vectors containing mouse Csf1r control elements direct macrophage-restricted expression in multiple species of birds and mammals.

Clare Pridans, Simon Lillico, Bruce Whitelaw, David A Hume

Open access · goldAbstract read
In one paragraph

Article in Molecular therapy. Methods & clinical development, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Transcriptomic Analysis of Rat Macrophages.Frontiers in immunology · 2020
    Article
  3. Article
  4. Article
  5. A Csf1r-EGFP Transgene Provides a Novel Marker for Monocyte Subsets in Sheep.Journal of immunology (Baltimore, Md. : 1950) · 2016
    Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Clare PridansThe Roslin Institute, Royal (Dick) School of Veterinary Studies, University of Edinburgh, Scotland , UK.
Simon LillicoThe Roslin Institute, Royal (Dick) School of Veterinary Studies, University of Edinburgh, Scotland , UK.
Bruce WhitelawThe Roslin Institute, Royal (Dick) School of Veterinary Studies, University of Edinburgh, Scotland , UK.
David A HumeThe Roslin Institute, Royal (Dick) School of Veterinary Studies, University of Edinburgh, Scotland , UK.
Roslin Institute · GB

Funding

Biotechnology and Biological Sciences Research Council BB/I013113/1Biotechnology and Biological Sciences Research Council BBS/E/D/05251442Biotechnology and Biological Sciences Research Council BBS/E/D/05251443Biotechnology and Biological Sciences Research Council BBS/E/D/05251444Biotechnology and Biological Sciences Research Council BBS/E/D/05251445Biotechnology and Biological Sciences Research Council BBS/E/D/20251969Biotechnology and Biological Sciences Research Council BBS/E/D/20320000Biotechnology and Biological Sciences Research Council BBS/E/R/00001620Medical Research Council G0901193
6 · The paper itself

Abstract

The development of macrophages requires signaling through the lineage-restricted receptor Csf1r. Macrophage-restricted expression of transgenic reporters based upon Csf1r requires the highly conserved Fms-intronic regulatory element (FIRE). We have created a lentiviral construct containing mouse FIRE and promoter. The lentivirus is capable of directing macrophage-restricted reporter gene expression in mouse, rat, human, pig, cow, sheep, and even chicken. Rat bone marrow cells transduced with the lentivirus were capable of differentiating into macrophages expressing the reporter gene in vitro. Macrophage-restricted expression may be desirable for immunization or immune response modulation, and for gene therapy for lysosomal storage diseases and some immunodeficiencies. The small size of the Csf1r transcription control elements will allow the insertion of large "cargo" for applications in gene therapy and vaccine delivery.

Identifiers

PMID26015955
PMCPMC4362345
OpenAlexW1973709077

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.